FORM 6-K
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

Report of Foreign Private Issuer

Pursuant to Rule 13a-16 or 15d-16
of the Securities Exchange Act of 1934


For the month of January, 2005

Commission File Number

0000882361


LORUS THERAPEUTICS INC.
(Translation of registrant's name into English)

2 MERIDIAN ROAD

TORONTO, ONTARIO M9W 4Z7

CANADA
(Address of principal executive offices)


Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F.........                                          Form 40-F  XXX



Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

Yes ......                                       No ..XX


Signatures

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

LORUS THERAPEUTICS INC.
(Registrant)

By:  "Shane A. Ellis"
Shane A. Ellis - Vice President
Legal Affairs and Corporate Secretary





Date  January 21, 2005

* Print the name and title of the signing officer under his signature.

                                                                   









[lorus002.gif]






[lorus004.gif]






[lorus006.gif]






[lorus008.gif]






[lorus010.gif]






[lorus012.gif]






[lorus014.gif]






[lorus016.gif]






[lorus018.gif]






[lorus020.gif]






[lorus022.gif]






[lorus024.gif]






[lorus026.gif]






[lorus028.gif]






[lorus030.gif]






[lorus032.gif]






[lorus034.gif]






[lorus036.gif]






[lorus038.gif]






[lorus040.gif]






[lorus042.gif]






[lorus044.gif]






[lorus046.gif]






[lorus048.gif]






[lorus050.gif]






[lorus052.gif]






[lorus054.gif]